In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017

In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020

Published:2022-12-21 Issue:6 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Jean Shio-Shin¹²³,Yang Hung-Jen⁴,Hsieh Po-Chuen²,Huang Yu-Tsung⁵⁶,Ko Wen-Chien⁷,Hsueh Po-Ren⁵⁸⁹¹⁰⁶^ORCID

Affiliation:

1. Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan

2. Department of Pharmacy, College of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan

3. Department of Critical Care Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan

4. Department of Family Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan

5. Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

6. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

7. Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan

8. Department of Laboratory Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan

9. School of Medicine, China Medical University, Taichung, Taiwan

10. Ph.D Program for Aging, School of Medicine, China Medical University, Taichung, Taiwan

Abstract

In addition to monitoring the antifungal susceptibilities of clinically important fungi, reviewing the PK/PD indices and the clinical therapy experience of antifungals under evaluation are important to guide an appropriate antifungal prescription. The efficacies of liposomal amphotericin B complex and anidulafungin for the treatment of pulmonary aspergillosis caused by different Aspergillus species need to be periodically evaluated in the future.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02965-22

Reference52 articles.

1. Invasive Candidiasis Species Distribution and Trends, United States, 2009–2017

2. To what degree could clinical trials in evidence based medicine reflect reality in the treatment of candidemia?

3. Risk factors and prognoses of invasive Candida infection in surgical critical ill patients with perforated peptic ulcer

4. Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan

5. Clinical Characteristics and Prognostic Risk Factors of Patients With Proven Invasive Pulmonary Aspergillosis: A Single-Institution Retrospective Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis;Critical Care;2023-10-03

2. Succinylation modification provides new insights for the treatment of immunocompromised individuals with drug-resistant Aspergillus fumigatus infection;Frontiers in Immunology;2023-04-17